Polymorphisms of STAT6 and specific serum IgE levels in patients with penicillin allergy.
- Published in:
- International Journal of Clinical Pharmacology & Therapeutics, 2012, v. 50, n. 7, p. 461, doi. 10.5414/CP201691
- By:
- Publication type:
- Article
Works by Hai-Ling Qiao
Results: 16
1
2
Effect of P450 Oxidoreductase Polymorphisms on the Metabolic Activities of Ten Cytochrome P450s Varied by Polymorphic CYP Genotypes in Human Liver Microsomes.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 47, n. 4, p. 1604, doi. 10.1159/000490934
- By:
- Publication type:
- Article
3
High CYP2E1 activity aggravates hepatofibrosis by limiting macrophage polarization towards the M2 phenotype.
- Published in:
- Molecular Carcinogenesis, 2019, v. 58, n. 8, p. 1481, doi. 10.1002/mc.23029
- By:
- Publication type:
- Article
4
From hepatofibrosis to hepatocarcinogenesis: Higher cytochrome P450 2E1 activity is a potential risk factor.
- Published in:
- Molecular Carcinogenesis, 2018, v. 57, n. 10, p. 1371, doi. 10.1002/mc.22851
- By:
- Publication type:
- Article
5
Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.
- Published in:
- Bioscience Reports, 2017, v. 37, n. 6, p. 1, doi. 10.1042/BSR20171161
- By:
- Publication type:
- Article
6
Effects of Gene Polymorphisms, Metabolic Activity, and Content of Alcohol Dehydrogenase and Acetaldehyde Dehydrogenases on Prognosis of Hepatocellular Carcinoma Patients.
- Published in:
- Turkish Journal of Gastroenterology, 2022, v. 33, n. 7, p. 606, doi. 10.5152/tjg.2022.21340
- By:
- Publication type:
- Article
7
Inhibition of Baicalin on Metabolism of Phenacetin, a Probe of CYP1A2, in Human Liver Microsomes and in Rats.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0089752
- By:
- Publication type:
- Article
8
Contribution of Baicalin on the Plasma Protein Binding Displacement and CYP3A Activity Inhibition to the Pharmacokinetic Changes of Nifedipine in Rats <i>In Vivo</i> and <i>In Vitro</i>.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0087234
- By:
- Publication type:
- Article
9
Concentration-Dependent Inhibitory Effect of Baicalin on the Plasma Protein Binding and Metabolism of Chlorzoxazone, a CYP2E1 Probe Substrate, in Rats In Vitro and In Vivo.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0053038
- By:
- Publication type:
- Article
10
Polymorphisms and haplotype analysis of IL-4Rα Q576R and I75V in patients with penicillin allergy.
- Published in:
- European Journal of Clinical Pharmacology, 2009, v. 65, n. 9, p. 895, doi. 10.1007/s00228-009-0659-y
- By:
- Publication type:
- Article
11
Relationships between specific serum IgE, IgG, IFN-γ level and IFN-γ, IFNR1 polymorphisms in patients with penicillin allergy.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 10, p. 971, doi. 10.1007/s00228-008-0486-6
- By:
- Publication type:
- Article
12
Association of IL-10 level and IL-10 promoter SNPs with specific antibodies in penicillin-allergic patients.
- Published in:
- European Journal of Clinical Pharmacology, 2007, v. 63, n. 3, p. 263, doi. 10.1007/s00228-006-0245-5
- By:
- Publication type:
- Article
13
Pharmacokinetics of three proton pump inhibitors in Chinese subjects in relation to the CYP2C19 genotype.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 2, p. 107, doi. 10.1007/s00228-005-0063-1
- By:
- Publication type:
- Article
14
Polymorphisms of IL–13 and IL–4–IL–13–SNPs in patients with penicillins allergy.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 11, p. 803, doi. 10.1007/s00228-005-0047-1
- By:
- Publication type:
- Article
15
Inhibitory effect of chlormethiazole on the toxicokinetics of diethylnitrosamine in normal and hepatofibrotic rats.
- Published in:
- Drug & Chemical Toxicology, 2019, v. 42, n. 6, p. 600, doi. 10.1080/01480545.2018.1455204
- By:
- Publication type:
- Article
16
Preclinical Pharmacokinetics, Tissue Distribution, and Plasma Protein Binding of Sodium (±)-5-Bromo-2-(α-Hydroxypentyl) Benzoate (BZP), an Innovative Potent Anti-ischemic Stroke Agent.
- Published in:
- Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00255
- By:
- Publication type:
- Article